2017 Medicaid Meaningful Use Stage 2 Objective 10: Public Health - Specialized Registry Reporting

Overview
This measure requires that an eligible provider is in active engagement to submit data to a specialized registry.

Workflow
While Practice Fusion does not support direct integration for this measure, providers may use electronic submission methods beyond the functions of CEHRT to meet the requirements for the Specialized Registry Reporting measure. Please refer to the steps below for assistance in meeting this measure.

  1. Register within 60 days of the start of the reporting period. For all providers meeting Meaningful Use in 2017 (who have attested previously), this registration deadline is March 1, 2017.

  2. Refer to the CMS FAQ regarding what can count as a specialized registry: FAQ #22517.

  3. Discuss the reporting requirements with your particular specialized registry.
  4. If the registry allows you to export CCDAs and submit them to the registry, follow the instructions outlined in our Knowledge Base for exporting a CCDA: What are clinical documents and how to I generate them?

  5. If the registry requires additional reporting requirements, Practice Fusion will be unable to support reporting to that registry.

Exclusion
Any eligible professional (EP) that meets at least 1 of the following criteria may be excluded from this objective:

  • Does not diagnose or treat any disease or condition associated with or collect relevant data that is required by a specialized registry in their jurisdiction during the EHR reporting period.
  • Operates in a jurisdiction for which no specialized registry is capable of accepting electronic registry transactions in the specific standards required to meet the CEHRT definition at the start of the EHR reporting period.
  • Operates in a jurisdiction where no specialized registry for which the EP, eligible hospital, or CAH is eligible has declared readiness to receive electronic registry transactions at the beginning of the EHR reporting period.

How is active engagement defined?
Active engagement means that the provider is in the process of moving towards sending "production data" to a public health agency or clinical data registry, or is sending production data to a public health agency or clinical data registry.

  1. Active Engagement Option 1– Completed Registration to Submit Data: The EP registered to submit data with the PHA or, where applicable, the CDR to which the information is being submitted; registration was completed within 60 days after the start of the EHR reporting period; and the EP is awaiting an invitation from the PHA or CDR to begin testing and validation. This option allows providers to meet the measure when the PHA or the CDR has limited resources to initiate the testing and validation process. Providers that have registered in previous years do not need to submit an additional registration to meet this requirement for each EHR reporting period.

  2. Active Engagement Option 2 - Testing and Validation: The EP is in the process of testing and validation of the electronic submission of data. Providers must respond to requests from the PHA or, where applicable, the CDR within 30 days; failure to respond twice within an EHR reporting period would result in that provider not meeting the measure.

  3. Active Engagement Option 3 – Production: The EP has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA or CDR.

More Information
Review the CMS specifications for more information about this measure. 

For more information on the EHR Incentive Program, please visit our Meaningful Use Center.


Meaningful Use

  1. What is Meaningful Use?
  2. How do I attest for Meaningful Use?
  3. How does the Meaningful Use Dashboard work?
  4. 2018 Medicaid Meaningful Use Stage 2 Objective 1: Protect Patient Health Information
  5. 2018 Medicaid Meaningful Use Stage 2 Objective 2: Clinical Decision Support
  6. 2018 Medicaid Meaningful Use Stage 2 Objective 3: CPOE for Medication, Lab, and Radiology Orders
  7. 2018 Medicaid Meaningful Use Stage 2 Objective 4: Electronic Prescribing (eRx)
  8. 2018 Medicaid Meaningful Use Stage 2 Objective 5: Health Information Exchange
  9. 2018 Medicaid Meaningful Use Stage 2 Objective 6: Patient-Specific Education
  10. 2018 Medicaid Meaningful Use Stage 2 Objective 7: Medication Reconciliation
  11. 2018 Medicaid Meaningful Use Stage 2 Objective 8: Patient Electronic Access
  12. 2018 Medicaid Meaningful Use Stage 2 Objective 9: Secure Electronic Messaging
  13. 2018 Medicaid Meaningful Use Stage 2 Objective 10: Public Health Reporting
  14. 2017 Medicaid Meaningful Use Stage 2 Objective 1: Protect Patient Health Information
  15. 2017 Medicaid Meaningful Use Stage 2 Objective 2: Clinical Decision Support
  16. 2017 Medicaid Meaningful Use Stage 2 Objective 3: CPOE for Medication, Lab, and Radiology Orders
  17. 2017 Medicaid Meaningful Use Stage 2 Objective 4: Electronic Prescribing (eRx)
  18. 2017 Medicaid Meaningful Use Stage 2 Objective 5: Health Information Exchange
  19. 2017 Medicaid Meaningful Use Stage 2 Objective 6: Patient-Specific Education
  20. 2017 Medicaid Meaningful Use Stage 2 Objective 7: Medication Reconciliation
  21. 2017 Medicaid Meaningful Use Stage 2 Objective 8: Patient Electronic Access
  22. 2017 Medicaid Meaningful Use Stage 2 Objective 9: Secure Electronic Messaging
  23. 2017 Medicaid Meaningful Use Stage 2 Objective 10: Public Health Reporting
  24. 2017 Medicaid Meaningful Use Stage 2 Objective 10: Public Health - Immunization Registry Data Submission
  25. 2017 Medicaid Meaningful Use Stage 2 Objective 10: Public Health - Syndromic Surveillance Data Submission
  26. 2017 Medicaid Meaningful Use Stage 2 Objective 10: Public Health - Specialized Registry Reporting
  27. What are the Modified Stage 2 Meaningful Use requirements for 2017?
  28. What are the exclusions for Meaningful Use?
  29. What patients are counted for Meaningful Use?
  30. How do the components of a chart note relate to Meaningful Use?
  31. How do I print the Meaningful Use Dashboard?
  32. How do I minimize or refresh CDS notifications?
  33. How can I send a referral using Direct Messaging?
  34. How does patient portal access and auto-invite relate to Meaningful Use?
  35. What constitutes a "unique" patient?
  36. Meaningful Use attestation for previous years
  37. How do Meaningful Use payment adjustments work?
  38. How do I apply for a Meaningful Use Hardship Exception?
  39. How do I find Practice Fusion's CMS EHR Certification ID?
  40. How do I register for the Medicaid Meaningful Use Program?
  41. Can I change, modify, or cancel my attestation?
  42. How do I choose my reporting period duration for Medicaid Meaningful Use?
  43. Is Practice Fusion a certified EHR?
  44. Patient records maintained in the EHR for Meaningful Use attestation
  45. How do I get my AIU letter from Practice Fusion?
  46. How do I report eCQMs for Medicaid Meaningful Use?
  47. Do I have to meet all 10 objectives to achieve Meaningful Use?
  48. Can I participate in both MIPS (Medicare) and Meaningful Use (Medicaid)?
  49. Are there patient education materials available in Spanish?
  50. How do I select or change my reporting period start date?
  51. When do I need to sign chart notes for Meaningful Use? Can I sign a chart after the reporting period?
  52. How do I contact my state about the Medicaid EHR Incentive Program?
  53. How do I qualify for Meaningful Use if I see patients in multiple locations?
  54. How many exclusions can each provider claim for meaningful use?
  55. How do I use multiple EHR's to qualify for Medicaid Meaningful Use?
  56. What stage of Medicaid Meaningful Use am I in?
  57. How do I prepare for the PQRS Penalty Informal Review?
  58. How do I prepare for a Meaningful Use audit?
  59. How do I batch export patient data from the EHR?
  60. How can I report CQMs for PQRS?
  61. Diabetes: Low Density Lipoprotein (LDL) Management (CMS 163v4)
  62. Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control (CMS 182v5)
  63. Use of Appropriate Medications for Asthma (CMS 126v4)

Feedback and Knowledge Base